Medifast Inc.
MED | NYSE
$12.26
+$0.49 (+4.16%)
At close: Sep 21, 2026, 4:00 PM ET
$12.26
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -6.28 | 92.74 | 7.39 | 9 | 14.95 | 22.46 |
PEG Ratio | 0.01 | -0.95 | -0.25 | -1.06 | 0.25 | 0.70 |
PS Ratio | 0.30 | 0.32 | 0.68 | 0.81 | 1.61 | 2.47 |
PB Ratio | 0.59 | 0.92 | 3.63 | 8.33 | 12.11 | 14.70 |
P/FCF Ratio | 93.90 | 11.31 | 5.18 | 7.26 | 40.63 | 16.59 |
P/OCF Ratio | 17.09 | 7.87 | 4.95 | 6.64 | 25.93 | 15.92 |
OCF/S Ratio | 1.78 | 4.06 | 13.77 | 12.17 | 6.20 | 15.53 |
Debt / Equity Ratio | 0.08 | 0.08 | 0.11 | 0.17 | 0.16 | 0.07 |
Quick Ratio | 4.22 | 2.68 | 1.84 | 0.74 | 0.75 | 1.62 |
Current Ratio | 4.69 | 3.34 | 2.43 | 1.58 | 1.81 | 2.10 |
Asset Turnover | 1.50 | 2.12 | 3.46 | 5.06 | 3.83 | 3.39 |
Interest Coverage | n/a | n/a | n/a | 263.63 | 936.11 | n/a |
Return on Equity | -9.39% | 1% | 49.34% | 92.60% | 81.01% | 65.41% |
Return on Assets | -7.26% | 0.74% | 32.08% | 45.40% | 41.18% | 37.26% |
Return on Invested Capital | -6.50% | 0.70% | 43.66% | 79.60% | 69.83% | 61.03% |
Dividend Yield | 0.17% | 0.37% | 9.98% | 5.55% | 2.60% | 2.30% |
Payout Ratio | -1.04% | 34.19% | 73.45% | 49.89% | 38.93% | 51.71% |
FCF Payout Ratio | -3.05% | 7.40% | 54.91% | 42.93% | 126.62% | 40.14% |
Gross Profit Margin | 71.33% | 73.80% | 72.37% | 71.34% | 73.89% | 74.65% |
Net Profit Margin | -4.84% | 0.35% | 9.27% | 8.98% | 10.75% | 11% |
Pretax Profit Margin | -1.46% | 0.63% | 12.01% | 11.51% | 14.16% | 14.36% |
Operating Profit Margin | -3.68% | 0.48% | 11.79% | 11.56% | 14.17% | 14.35% |
FCF Margin | 0.32% | 2.83% | 13.17% | 11.13% | 3.95% | 14.90% |
EBITDA Margin | 1.26% | 2.74% | 13.24% | 12.24% | 14.61% | 14.81% |
Add to Watchlist
Select watchlists to add or remove MED